Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

TELRAN Launch

1 Feb 2011 07:00

RNS Number : 4183A
Toumaz Limited
01 February 2011
 



1 February 2011

 

Toumaz Limited

 

Launch of world's lowest power wireless radio System-on-Chip

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in low cost, ultra low power wireless communications and broadcast technology, has launched TELRAN, its ultra-low energy wireless radio System-on-Chip.

 

Toumaz has already received its first orders for the product and will commence shipment in February. An agreement with a worldwide distributor will be concluded shortly.

 

Built on Toumaz's proprietary AMx™ low voltage mixed analogue and digital signal technology, TELRAN is the lowest power sub-1GHz complete radio currently available and addresses the wider low energy wireless communications market, delivering much longer life from low voltage battery-based systems without compromising on performance. 

 

A significant customer benefit is that the device is simple to use and does not need specialist programming tools, substantially reducing the cost of system development. Target applications include the development of two-way communication remote controls for consumer electronic devices; wireless sensor networks based on TELRAN sensor nodes and basestations; environment monitoring and room temperature control; remote control toys and games; and smart metering using TELRAN wireless sensor networks to connect multiple meters for the two-way transmission of data.

 

Professor Chris Toumazou, Toumaz Chief Executive, commented:

 

"With this important addition to our 'Connected Consumer' portfolio, we are harnessing our strengths in ultra-low energy wireless healthcare to create solutions for high-volume consumer markets with the world's lowest power radio.

 

"We are excited by the product opportunities that TELRAN enables, as it is well placed to take advantage of the huge growth in wireless devices beyond the mobile phone and healthcare space."

 

 

Enquiries:

 

Toumaz Limited 

020 7355 0036

Chris Toumazou, Chief Executive Officer

 

Patrick Stephansen, Chief Financial Officer

 

 

 

FinnCap

020 7600 1658

Charles Cunningham (Corporate Finance)

 

Brian Patient (Corporate Broking)

 

 

 

College Hill

020 7457 2020

Adrian Duffield/Rozi Morris

 

About Toumaz - (www.toumaz.com)

 

Toumaz is pioneering low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.

 

Targeting the Healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in real-time wireless monitoring of the body's vital signs. Sensium has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.

 

Toumaz also uses its ultra low power expertise to design devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to leaders in the digital radio market, such as PURE. 

 

Toumaz is an AIM listed company (AIM: TMZ) with development centres in Oxford, UK and Taipei City, Taiwan.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSDEFAFFFSEFF
Date   Source Headline
20th Feb 201210:16 amRNSHolding(s) in Company
16th Feb 20127:00 amRNSCompletion of placing
13th Feb 20127:00 amRNSPlacing raises £11.2m
13th Feb 20127:00 amRNSTrading update
3rd Jan 20127:00 amRNSSubsidiary established with Imagination Technologi
24th Oct 20117:00 amRNSTelran distribution clearance
21st Sep 20117:00 amRNSHalf year results
9th Aug 20114:52 pmRNSNotice of Results
29th Jul 20117:00 amRNSHalf year trading update
11th Jul 20117:00 amRNSFDA approval for Sensium
11th Jul 20117:00 amRNSJV established with CCE
5th May 20115:24 pmRNSResult of AGM
29th Mar 20117:00 amRNSFull year results
16th Mar 20113:16 pmRNSNotice of Results
16th Mar 20113:05 pmRNSHolding(s) in Company
3rd Mar 20114:34 pmRNSIssue of Equity
2nd Mar 20118:14 amRNS£1.8m Raised
10th Feb 20117:41 amRNSStrategic Investment
1st Feb 20117:00 amRNSTELRAN Launch
1st Feb 20117:00 amRNSYear End Trading Update
30th Nov 20107:00 amRNSXENIF processor in production
15th Sep 20107:00 amRNSInterim Results
24th Aug 20109:33 amRNSIssue of Equity
11th Aug 201011:52 amRNSNotice of Results
27th Jul 20107:00 amRNSLicense agreement
15th Jul 201010:19 amRNSIssue of Equity and Exercise of Options
30th Jun 20107:00 amRNSTrading Update
16th Jun 20108:49 amRNSAnnual Financial Report
26th May 20109:07 amRNSChange of Name
10th May 20102:52 pmRNSResult of AGM
30th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSQuanta takes strategic stake
11th Mar 20104:27 pmRNSDirector dealings
10th Mar 201011:26 amRNSNotice of Results
23rd Feb 20107:00 amRNSClinical Trial Update
1st Feb 20102:02 pmRNSExercise of Options - replacement
29th Jan 201012:33 pmRNSExercise of Options
22nd Dec 200911:19 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSHolding(s) in Company
17th Dec 20093:10 pmPRNResult of EGM
14th Dec 20093:34 pmPRNDirector/PDMR Shareholding
1st Dec 20097:00 amPRNProposed Placing and Update
9th Nov 20091:20 pmRNSNational Microelectronics Institute Award
2nd Nov 20097:00 amPRNSensium Digital Plaster European Trial
28th Sep 20097:00 amPRNHalf-yearly Report
22nd Sep 200912:16 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSCorrection re holding in company
10th Sep 20097:00 amRNSHolding(s) in Company
7th Aug 200912:01 pmRNSHolding(s) in Company
22nd Jul 200911:21 amPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.